CHARM Preserved trial
Last reviewed 02/2023
The CHARM-Preserved trial recruited 3023 patients with heart failure but no evidence of left ventricular dysfunction. Patients were randomised to treatment with candesartan or placebo.
There was no reduction in the primary outcome of the trial however there was a small reduction in admissions to hospital with heart failure.
Reference: